U.S. pharma large copyright scrapped two experimental weight loss capsules final year—a the moment-day-to-day tablet, lotiglipron, as a result of elevated liver enzymes in addition to a twice-daily pill, danuglipron, resulting from strong Uncomfortable side effects—but CEO Albert Bou